General Therapeutics is a pioneering biotech company committed to transforming the future of RNA therapeutics and vaccine delivery. Our mission is to develop innovative solutions that address the limitations of current technologies, ensuring safer, more effective treatments for global health challenges.
At the core of our work are our cutting-edge Ionizable lipids, non-reactogenic LNP, and QuikLNP formulation technologies, which promote the ultimate safety and accessibility of RNA medicines.
Our interdisciplinary team integrates advanced lipid chemistry, computational modeling, and rigorous in vivo experimentation to drive innovation. Focused on reducing reactogenicity, EAs, and enhancing therapeutic outcomes, we aim to deliver groundbreaking RNA-based solutions for infectious diseases, oncology, and beyond.
At General Therapeutics, we are committed to shaping the future of precision medicine and improving lives worldwide.
Company Details
- Employees
- 1
- Address
- Gaithersburg, Md 20878, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.generaltx.com
- HQ
- Gaithersburg, MD
General Therapeutics Questions
General Therapeutics's website is http://www.generaltx.com
General Therapeutics's LinkedIn profile is https://www.linkedin.com/company/generaltx
General Therapeutics has
1 employees.
View email and phone details for 1
employees at General Therapeutics.
General Therapeutics's industry is
Biotechnology Research
General Therapeutics's top competitors are
Nanotech Pharma Inc.,
Novoprotein,
Simple Biologics,
Dc Chemicals Limited,
Essenlix Corporation,
Amar Biosystems,
Nostos Biopharma Consulting,
C3h, Catalytic Capital For Climate And Health,
Cytodigm,
Acon Pharmaceuticals.
General Therapeutics's categories are Biotechnology Research
